| First Author | Liu Y | Year | 2022 |
| Journal | iScience | Volume | 25 |
| Issue | 10 | Pages | 105121 |
| PubMed ID | 36185365 | Mgi Jnum | J:351523 |
| Mgi Id | MGI:7345182 | Doi | 10.1016/j.isci.2022.105121 |
| Citation | Liu Y, et al. (2022) Mixed lineage kinase-like protein protects against Clostridium perfringens infection by enhancing NLRP3 inflammasome-extracellular traps axis. iScience 25(10):105121 |
| abstractText | Despite intense research in understanding Clostridium perfringens (C. perfringens) pathogenesis, the mechanisms by which it is cleared from the host are largely unclarified. In C. perfringens gas gangrene and enterocolitis model, Mlkl (-/-) mice, lacking mixed lineage kinase-like protein (MLKL), are more susceptible to C. perfringens infection. Mlkl deficiency results in a defect in inflammasome activation, and IL-18 and IL-1beta releases. Exogenous administration of recombinant IL-18 is able to rescue the susceptibility of Mlkl (-/-) mice. Notably, K(+) efflux-dependent NLRP3 inflammasome signaling downstream of active MLKL promotes bacterial killing and clearance. Interestingly, the defect of bactericidal activity is also mediated by decreased classical extracellular trap formation in the absence of Mlkl. Our results demonstrate that MLKL mediates extracellular trap formation in a NLRP3 inflammasome-dependent manner. These findings highlight the requirement of MLKL for host defense against C. perfringens infection through enhancing NLRP3 inflammasome-extracellular traps axis. |
